Welcome to our dedicated page for Bolt Projects Holdings SEC filings (Ticker: BSLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bolt Projects Holdings, Inc. filings document a biomaterials company focused on beauty and personal care ingredients, its public-company securities, and its corporate-status transition. Recent Forms 25 and 15 cover the removal of the company’s common stock and warrants from Nasdaq listing and registration, along with the certification to terminate or suspend Exchange Act reporting obligations for those securities.
The company’s Form 8-K filings cover operating and financial updates, Regulation FD disclosures, auditor changes, internal-control matters, and going-concern language associated with its financial statements. Proxy and governance filings address shareholder voting mechanics, special meeting matters, bylaw amendments, quorum rules, universal proxy procedures, stockholder nominations, and related capital-structure disclosures for BSLK and BSLKW.
Bolt Projects Holdings, Inc. (BSLK) reported an insider transaction: the Interim CFO received 17,672 restricted stock units of common stock on 11/12/2025. The RSUs were fully vested at the date of grant and recorded at a price of $0.
Following the award, the reporting person beneficially owns 72,976 shares on a direct basis. The filing was submitted by one reporting person and reflects a routine equity grant under the company’s equity incentive plan.
Bolt Projects Holdings, Inc. (BSLK) reported Q3 2025 results. Revenue rose to $370 thousand from $5 thousand a year ago, producing gross income of $58 thousand. Operating expenses were $4.4 million, leading to a loss from operations of $4.4 million and a net loss of $7.5 million for the quarter. For the nine months, revenue was $1.8 million and net loss was $18.0 million.
Cash and cash equivalents were $4.7 million at September 30, 2025. The company reported negative net working capital of $3.3 million, long‑term debt of $12.9 million, and a stockholders’ deficit of $12.7 million. Management states that these conditions raise substantial doubt about the company’s ability to continue as a going concern.
The company effected a 1‑for‑20 reverse stock split on April 21, 2025. Shares outstanding were 3,706,197 at September 30, 2025; as of November 7, 2025, shares outstanding were 4,366,123. Warrants remain outstanding, and fair‑value remeasurements affected other income/expense during the period.
Bolt Projects Holdings, Inc. filed a current report outlining that it has released financial results for the three months ended September 30, 2025 and shared a business update. The company reported these details through a press release dated November 12, 2025.
The press release is included as Exhibit 99.1 and is described as being furnished rather than filed, which means it is not subject to certain liability provisions of the securities laws and will only be incorporated into other documents if explicitly stated. The filing also notes the company’s common stock and warrants trade on The Nasdaq Stock Market under the symbols BSLK and BSLKW, respectively.
Bolt Projects Holdings (BSLK) is asking stockholders to approve, under Nasdaq Listing Rule 5635(d), the issuance of the maximum number of common shares issuable upon conversion of secured convertible notes and the exercise of related warrants expected to be issued to Murchinson Ltd. The company describes a proposed up to $30 million 10% original issue discount convertible note financing to support working capital, including repayment of amounts owed to secured creditor Ginkgo Bioworks. The notes would bear 2.00% interest and mature 12 months from issuance, with equal monthly redemptions of 1/12th of the initial balance in cash or, subject to conditions, shares.
The structure contemplates an initial draw sized by formula and additional tranches subject to conditions, including trading volume and market capitalization thresholds. If paid in shares, the conversion price would be the lower of 115% of the price immediately preceding the initial closing or 90% of the lowest VWAP in the five trading days before each conversion. Warrants equal to 20% of principal divided by the initial conversion price would accompany the notes with a 3‑year term. The Board recommends voting FOR Proposal 1 and FOR adjournment authority if needed. If approved, existing holders face dilution and potential market pressure from resales. If not approved, the company states it cannot consummate the financing, would receive no proceeds, and that failure may impair its ability to continue as a going concern and could impact its Nasdaq listing. Holders of record as of October 20, 2025 (4,084,493 shares outstanding) may vote at the virtual meeting on December 3, 2025.
Bolt Projects Holdings (BSLK) furnished an 8‑K to announce a press release with business updates and preliminary, unaudited financial information for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1 and incorporated by reference.
The company notes that the information under Item 2.02, including Exhibit 99.1, is being furnished, not filed under the Exchange Act. This distinction limits its use for certain liability purposes and incorporation into Securities Act filings unless expressly stated.
Bolt Projects Holdings, Inc. filed Prospectus Supplement No. 10 under Rule 424(b)(3) to update its March 27, 2025 prospectus by incorporating the company’s Form 8‑K filed on October 17, 2025. The 8‑K reports that the Board approved and adopted amendments to the company’s Amended and Restated Bylaws, effective October 17, 2025. The full text of the amended bylaws is provided as Exhibit 3.1. The supplement is intended to be read together with the existing prospectus.
Bolt Projects Holdings, Inc. filed Prospectus Supplement No. 2 under Rule 424(b)(3), updating its S-1 prospectus (No. 333-290557) with information from a Form 8-K.
On October 17, 2025, the board approved and adopted Amended and Restated Bylaws, effective the same day. The supplement directs readers to the full bylaws text attached as Exhibit 3.1 to the 8-K and to keep this supplement with the prospectus.
Bolt Projects Holdings, Inc. filed a Prospectus Supplement No. 2 under Rule 424(b)(3) to update its S-1 prospectus by incorporating its Form 8-K dated October 17, 2025.
According to the 8-K, the Board of Directors approved and adopted amendments to the company’s Amended and Restated Bylaws, effective October 17, 2025. The full text of the amended bylaws is provided as Exhibit 3.1 and incorporated by reference.
Bolt Projects Holdings, Inc. filed Prospectus Supplement No. 10 under Rule 424(b)(3), which updates the April 3, 2025 prospectus by incorporating the company’s Current Report on Form 8‑K filed on October 17, 2025.
The Form 8‑K states the Board approved and adopted amendments to the company’s Amended and Restated Bylaws, effective October 17, 2025. The complete text of the amended bylaws is provided as Exhibit 3.1 and is incorporated by reference.
Bolt Projects Holdings (BSLK) is asking stockholders to approve, for purposes of Nasdaq Listing Rule 5635(d), the issuance of the maximum number of shares that could be issued upon conversion of secured convertible notes and the exercise of related warrants expected to be sold to Murchinson Ltd. A virtual special meeting is set for December 3, 2025 at 11:00 a.m. Eastern Time.
The proposed financing contemplates convertible notes with up to $30 million aggregate principal, bearing 2.00% interest, maturing in 12 months, and amortizing monthly in cash or, subject to conditions, in shares. Conversion mechanics reference the lower of 115% of the price immediately before closing or 90% of the lowest five‑day VWAP for share redemptions. The Investor would receive a second lien on Bolt Threads, Inc. assets (subject to a subordination agreement) that could step up to first lien upon repayment of senior debt.
Warrants would be issued equal to 20% of note principal divided by the initial conversion price, with a three‑year term and an exercise price set at that initial conversion price. Approval would allow potential future share issuance, which the company notes could dilute existing holders and pressure the stock price. If not approved, the company states it cannot complete the financing, which may impair its ability to continue as a going concern and could affect its Nasdaq listing.